earnings
confidence high
sentiment positive
materiality 0.75
Biotricity Q3 FY25 revenue $3.6M (+21.7% YoY); net loss down 56.7% to $1.32M
BIOTRICITY INC.
2025-Q3 EPS
reported -$0.50
vs consensus -$0.08
▼ miss
(-510.3%)
- Gross margin improved to 76.4% from 72.9% YoY; recurring tech fees 94% of revenue at 81.4% gross profit.
- Recurring Technology Fees rose 21.8% YoY to $3.39M; pure SaaS revenue up 22%.
- SG&A reduced 20.5% to $2.38M from $3.0M; positive cash flow from operations second consecutive quarter, up 114.5% sequentially.
- Net loss per share improved to $0.054 from $0.339 in Q3 FY24.